Still, a multicenter, randomized, open-label, Phase IV study reported that, in some acromegalic patients treated with PASI, hyperglycemia could be effectively controlled by metformin, eventually followed by incretin-based therapy [51]. The gene discussed is GCG; the disease is Hyperglycemia.